Drug User Health

overview

Since its founding in 1992, NASTAD members have been concerned about the role of substance use in the transmission of HIV (and later HCV), health outcomes for persons living with HIV and hepatitis who use drugs and the structural and policy barriers to effectively address the prevention, care, and treatment needs of persons who inject drugs. To address the prevention, care, and treatment and policy needs related to drug user health, NASTAD has partnered with federal, state, and local governments and for- and not-for-profit community partners to continue to raise awareness of and action to address this important population. In addition to partnerships with key organizations, NASTAD has produced documents, provided technical assistance to our members and advocated for an effective science based public health approach to addressing the needs of people who inject drugs.